Trials / Sponsors / Xianhai Mao
Xianhai Mao
Academic / Other · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | TQB2450 Plus Anlotinib as Adjuvant Therapy in HCC Patients at High Risk of Recurrence After Resection Hepatocellular Carcinoma, Adjuvant Therapy | Phase 2 | 2022-01-06 |